Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Frontiers in Oncology|July 26, 2021
Mechanisms of Action of the New Antibodies in Use in Multiple MyelomaAlessandra Romano, Paola Storti, Valentina Marchica, et al.
British Journal of Haematology|March 13, 2020
CD14+ CD16+ monocytes are involved in daratumumab-mediated myeloma cells killing and in anti-CD47 therapeutic strategyPaola Storti, Rosanna Vescovini, Federica Costa, et al.
Frontiers in Immunology|February 27, 2025
Monoclonal anti-CD38 therapy in human myeloma: retrospects and prospectsAlberto L Horenstein, Angelo C Faini, Fabio Morandi, et al.
Journal of Clinical Medicine|September 9, 2020
Novel Approaches to Improve Myeloma Cell Killing by Monoclonal AntibodiesPaola Storti, Federica Costa, Valentina Marchica, et al.
Cells|July 2, 2021
Role of 1q21 in Multiple Myeloma: From Pathogenesis to Possible Therapeutic TargetsJessica Burroughs Garcìa, Rosa Alba Eufemiese, Paola Storti, et al.
Experimental Hematology|October 28, 2010
The proapoptotic effect of zoledronic acid is independent of either the bone microenvironment or the intrinsic resistance to bortezomib of myeloma cells and is enhanced by the combination with arsenic trioxideManuela Abeltino, Sabrina Bonomini, Marina Bolzoni, et al.
Experimental Hematology|November 27, 2012
Immunomodulatory drugs lenalidomide and pomalidomide inhibit multiple myeloma-induced osteoclast formation and the RANKL/OPG ratio in the myeloma microenvironment targeting the expression of adhesion moleculesMarina Bolzoni, Paola Storti, Sabrina Bonomini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 2010
Interleukin-27 acts as multifunctional antitumor agent in multiple myelomaClaudia Cocco, Nicola Giuliani, Emma Di Carlo, et al.
Cancer Research|August 16, 2008
CC-chemokine ligand 20/macrophage inflammatory protein-3α and CC-chemokine receptor 6 are overexpressed in myeloma microenvironment related to osteolytic bone lesionsNicola Giuliani, Gina Lisignoli, Simona Colla, et al.
Frontiers in Immunology|January 25, 2021
PD-L1/PD-1 Pattern of Expression Within the Bone Marrow Immune Microenvironment in Smoldering Myeloma and Active Multiple Myeloma PatientsFederica Costa, Rosanna Vescovini, Valentina Marchica, et al.
Pageof 5